Inbiogen Co. Ltd. (101140)
Market Closed
15 Oct, 06:30 AM
KRX SM KRX SM Primary ₩
4,935. 00
+40
+0.8172%
₩
114.33B Market Cap
- P/E Ratio
- Div Yield
2,312 Volume
- Eps
₩ 4,895
Previous Close Want to track 101140 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Inbiogen Co. Ltd. (101140) Statistics
Valuation metrics
Market Cap 114.33B
Enterprise value 51.23B
Trailing P/E (ttm) -1.19
Forward P/E -
PEG ratio -0.03
Price/Sales (ttm) 9.7
Price/Book (mrq) 0.02
Enterprise Value/Revenue 10.04
Enterprise Value/EBITDA 9.37
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.97K
Average volume (90 days) 5.16K
Price summary
52-Week low 4,255
52-Week high 14,300
Beta -
50-Day moving average 5,132.81
200-Day moving average 6,488.25
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 0:1
Last split Date 21 Sep 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -4.06%
Operating margin -0.77%
Operational effectiveness
Return on assets -0.14%
Return on equity -0.14%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 10,222.62
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -41,517.95
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4,685.67
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 1.37%
Book value per share (mrq) 283,437.6
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
